0000899243-16-025662 4 1 20160721 20160725 20160725 TPI COMPOSITES, INC 0001455684 3510 000000000 DE 8501 N SCOTTSDALE ROAD GAINEY CENTER II, SUITE 280 SCOTTSDALE AZ 85253 480-305-8910 8501 N SCOTTSDALE ROAD GAINEY CENTER II, SUITE 280 SCOTTSDALE AZ 85253 TPI COMPOSITES INC 20090206 ANGELENO INVESTORS II L P 0001357869 DE 1231 4 34 001-37839 161782936 2029 CENTURY PARK EAST SUITE 2980 LOS ANGELES CA 90067 310-552-2773 2029 CENTURY PARK EAST SUITE 2980 LOS ANGELES CA 90067 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-21 0 0001455684 TPI COMPOSITES, INC TPIC 0001357869 ANGELENO INVESTORS II L P 2029 CENTURY PARK EAST, SUITE 2980 LOS ANGELES CA 90067 0 0 1 0 Series B Warrants 8748.81 2016-07-21 4 X 0 16.5737 0.00 D Series B Convertible Preferred Stock 16.5737 0 D Series B Convertible Preferred Stock 2016-07-21 4 X 0 16.5737 0.00 A Common Stock 21261 190.9977 D Series B Convertible Preferred Stock 2016-07-21 4 S 0 10.2762 0.00 D Common Stock 13182 180.7215 D The Series B Warrants were deemed automatically exercised prior to the closing of the Issuer's initial underwritten public offering of Common Stock pursuant to a registration statement on Form S-1, which public offering has been declared effective by the SEC. These securities were exercisable for a period ending upon the earliest to occur of (i) seven (7) years after the Effective Date, (ii) the date of the Issuer's initial public offering, or (iii) the date of a merger event, as defined therein. The Series B Convertible Preferred Stock (the "Series B Shares") is convertible at any time into shares of the Issuer's Common Stock at the holder's election and automatically convert, upon the closing of the Issuer's initial public offering, into the number of shares of Common Stock shown in column 7 above. These securities do not have an expiration date. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 10.2762 of the Series B Shares to pay the exercise price and issuing to the Reporting Person the remaining 180.7215 Series B Shares. /s/ Steven G. Fishbach, Attorney-in-Fact 2016-07-25